E
MET icon

Ergoteles’s MetLife MET Stock Holding History

Ergoteles’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-135,362
Closed -$9.8M – 1559
2022
Q4 		$9.8M Sell
135,362
-48,122
-26% -$3.45M 0.36% 62
2022
Q3 		$11.2M Buy
183,484
+159,861
+677% +$10.2M 0.39% 37
2022
Q2 		$1.48M Sell
23,623
-257,968
-92% -$17.1M 0.04% 396
2022
Q1 		$19.8M Buy
+281,591
New +$19M 0.75% 23
2021
Q4 		– Sell
-8,076
Closed -$499K – 1456
2021
Q3 		$499K Sell
8,076
-8,008
-50% -$482K 0.02% 580
2021
Q2 		$963K Sell
16,084
-247,503
-94% -$15.7M 0.02% 516
2021
Q1 		$16M Buy
263,587
+227,887
+638% +$12.6M 0.5% 55
2020
Q4 		$1.68M Buy
+35,700
New +$1.55M 0.06% 267

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ergoteles's MET Position: Q1 2023 in Review

Ergoteles sold out of MetLife (MET) in Q1 2023, closing a stake of 135,362 shares — an estimated $9.8M sold.

Ergoteles first reported a position in MET in Q4 2020 and held it in 8 quarters. The position peaked at $19.8M in Q1 2022. 1,213 funds tracked by Wall St. Rank hold MET as of Q1 2023.

  • Ergoteles reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 135,362 MetLife shares in Q1 2023, an estimated $9.8M.
  • Ergoteles first reported a position in MetLife in Q4 2020 and held it in 8 quarters.
  • Ergoteles's MetLife position peaked at $19.8M in Q1 2022.
  • 1,213 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.